Linked Data API

Show Search Form

Search Results

386890
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Ministry of Defence more like this
star this property answering dept id 11 more like this
star this property answering dept short name Defence more like this
star this property answering dept sort name Defence more like this
star this property hansard heading Defence more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government over what periods in the last 30 years there has been a threat to the existence of the United Kingdom; and what was the average percentage of gross domestic product spent on defence in each of those years. more like this
star this property tabling member printed
Lord West of Spithead more like this
star this property uin HL999 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-08more like thismore than 2015-07-08
star this property answer text <p>The UK has, and continues to face, a broad range of complex threats both at home and abroad.</p><p>The table below shows the proportion of gross domestic product that the UK has spent on defence each year since 1985. This data is published annually by NATO as part of its Defence Expenditure publications.</p><p> </p><table><tbody><tr><td><p><strong>Year</strong></p></td><td><p><strong>Percentage of GDP spent on Defence</strong></p></td></tr><tr><td><p>1985</p></td><td><p>5.2</p></td></tr><tr><td><p>1986</p></td><td><p>4.9</p></td></tr><tr><td><p>1987</p></td><td><p>4.6</p></td></tr><tr><td><p>1988</p></td><td><p>3.2</p></td></tr><tr><td><p>1989</p></td><td><p>4.1</p></td></tr><tr><td><p>1990</p></td><td><p>4.1</p></td></tr><tr><td><p>1991</p></td><td><p>4.3</p></td></tr><tr><td><p>1992</p></td><td><p>3.8</p></td></tr></tbody></table><p> </p><p> </p><table><tbody><tr><td><p>1993</p></td><td><p>3.6</p></td></tr><tr><td><p>1994</p></td><td><p>3.4</p></td></tr><tr><td><p>1995</p></td><td><p>3.1</p></td></tr><tr><td><p>1996</p></td><td><p>3</p></td></tr><tr><td><p>1997</p></td><td><p>2.7</p></td></tr><tr><td><p>1998</p></td><td><p>2.6</p></td></tr><tr><td><p>1999</p></td><td><p>2.5</p></td></tr><tr><td><p>2000</p></td><td><p>2.5</p></td></tr><tr><td><p>2001</p></td><td><p>2.5</p></td></tr><tr><td><p>2002</p></td><td><p>2.4</p></td></tr><tr><td><p>2003</p></td><td><p>2.4</p></td></tr><tr><td><p>2004</p></td><td><p>2.2</p></td></tr><tr><td><p>2005</p></td><td><p>2.5</p></td></tr><tr><td><p>2006</p></td><td><p>2.4</p></td></tr><tr><td><p>2007</p></td><td><p>2.5</p></td></tr><tr><td><p>2008</p></td><td><p>2.6</p></td></tr><tr><td><p>2009</p></td><td><p>2.6</p></td></tr><tr><td><p>2010</p></td><td><p>2.6</p></td></tr><tr><td><p>2011</p></td><td><p>2.6</p></td></tr><tr><td><p>2012</p></td><td><p>2.2</p></td></tr><tr><td><p>2013</p></td><td><p>2.3</p></td></tr><tr><td><p>2014</p></td><td><p>2.2</p></td></tr><tr><td><p>2015</p></td><td><p>2.1</p></td></tr></tbody></table><p> </p>
unstar this property answering member printed Earl Howe more like this
star this property question first answered
less than 2015-07-08T15:34:22.203Zmore like thismore than 2015-07-08T15:34:22.203Z
star this property answering member
2000
star this property label Biography information for Earl Howe more like this
star this property tabling member
3834
unstar this property label Biography information for Lord West of Spithead more like this
386889
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Ministry of Defence more like this
star this property answering dept id 11 more like this
star this property answering dept short name Defence more like this
star this property answering dept sort name Defence more like this
star this property hansard heading Iraq: Armed Conflict more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what assessment they have made of whether driving Daesh out of Iraq would be a final military victory. more like this
star this property tabling member printed
Lord West of Spithead more like this
star this property uin HL998 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-07more like thismore than 2015-07-07
star this property answer text <p>ISIL must be defeated both in Iraq and Syria. This will take time and patience but it is a fight we must win. We are also clear that it cannot be achieved by military action alone which is why the UK supports inclusive governance in Iraq and political transition in Syria.</p> more like this
unstar this property answering member printed Earl Howe more like this
star this property question first answered
less than 2015-07-07T16:05:34.347Zmore like thismore than 2015-07-07T16:05:34.347Z
star this property answering member
2000
star this property label Biography information for Earl Howe more like this
star this property tabling member
3834
unstar this property label Biography information for Lord West of Spithead more like this
386888
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Amyloidosis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government which of the four phase 2 or 3 clinical trials for systemic amyloidosis approved since 2004 are still ongoing; and whether any of the trials have produced sufficient positive outcomes to encourage commercial development. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL997 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thismore than 2015-07-14
star this property answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p>
unstar this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN
HL995 more like this
HL996 more like this
star this property question first answered
less than 2015-07-14T15:34:29.553Zmore like thismore than 2015-07-14T15:34:29.553Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property attachment
1
unstar this property file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf more like this
star this property title 2013-14 Annual Report more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
386887
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Amyloidosis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether there are currently any trials for systemic amyloidosis in humans being conducted by the National Institute of Health Research charities or the commercial sector. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL996 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thismore than 2015-07-14
star this property answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p>
unstar this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN
HL995 more like this
HL997 more like this
star this property question first answered
less than 2015-07-14T15:34:29.297Zmore like thismore than 2015-07-14T15:34:29.297Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property attachment
1
unstar this property file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf more like this
star this property title 2013-14 Annual Report more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
386886
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Bone Marrow Disorders more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government whether they will place in the Library of the House any publications resulting from the phase 3 clinical trials approved for the potential treatment of systemic amyloidosis or multiple myeloma; and what is the National Institute of Health Research’s assessment of progress in these areas. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL995 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thismore than 2015-07-14
star this property answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p>
unstar this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN
HL996 more like this
HL997 more like this
star this property question first answered
less than 2015-07-14T15:34:29.197Zmore like thismore than 2015-07-14T15:34:29.197Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property attachment
1
unstar this property file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf more like this
star this property title 2013-14 Annual Report more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
386885
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Myeloma more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government when they expect the National Institute of Health Research Technology Assessment programme to publish initial findings from its assessment of the benefits of antibiotic prophylaxis and its effect on healthcare associated infections in myeloma patients. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL994 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-09more like thismore than 2015-07-09
star this property answer text <p>This trial is led by the University of Birmingham. The project is recruiting ahead of schedule and expects to reach its target of 800 in the near future. The target was to do so by the end of November 2015. Publication of initial findings is expected in 2017.</p><p> </p> more like this
unstar this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2015-07-09T13:00:57.7Zmore like thismore than 2015-07-09T13:00:57.7Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
386884
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Amyloidosis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what progress has been made on setting up a study to image amyloid deposition in systemic amyloidosis using hybrid positron emission tomography-magnetic resonance imaging; where the study is located; how many patients have been recruited; when the study is expected to complete its initial work; and where the results will be published. more like this
star this property tabling member printed
Lord Willis of Knaresborough more like this
star this property uin HL993 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thismore than 2015-07-14
star this property answer text <p>This is a single centre study at University College London Hospital. It has now been set up and one patient has been recruited and scanned. The current planned date for end of recruitment is 1 October 2016. It is anticipated that the data will be analysed and submitted for publication in a peer reviewed journal within a year of the end of recruitment.</p><p> </p> more like this
unstar this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2015-07-14T15:36:20.96Zmore like thismore than 2015-07-14T15:36:20.96Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
386883
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department for Energy and Climate Change more like this
star this property answering dept id 63 more like this
star this property answering dept short name Energy and Climate Change more like this
star this property answering dept sort name Energy and Climate Change more like this
star this property hansard heading Carbon Emissions more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what proportion of their 2020 carbon emissions reduction target they intend to achieve through the development of thermal heating capacity in the United Kingdom. more like this
star this property tabling member printed
Lord Judd more like this
star this property uin HL992 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-07more like thismore than 2015-07-07
star this property answer text <p>The Climate Change Act (2008) requires the Government to set legally binding ‘carbon budgets’ to meet the objective of reducing emissions by at least 80% in 2050 from 1990 levels. The Act requires that the UK’s emissions in the third carbon budget period, which covers 2020, are at least 34% below the 1990 baseline for emissions.</p><p>The Government has not set specific targets for how much of the emissions reductions required for each carbon budget should come from different emissions sources, for example heat, electricity or transport. This is to provide sufficient flexibility to ensure carbon savings are delivered across the economy in the most cost effective way.</p><p>However, DECC does produce projections of UK emissions that account for the impact of Government policies. The last projections published in September 2014 [1] showed that the UK was on track to meet the second (2013-17) and third (2018-22) budgets having already met the first carbon budget (2008-12).</p><p>In 2020, policies [2] which drive improvements in energy efficiency (across all sectors) are projected to contribute 61% of the total reduction in emissions and policies influencing the uptake of low-carbon heat technologies are projected to contribute 5%. Other policies such as Building Regulations also support the reduction of heat emissions from buildings for example through the requirement to install a condensing boiler in most cases when a boiler needs to be replaced.</p><p><em><strong>[1]</strong></em><em> Updated Energy and Emissions Projections: 2014 (DECC)</em></p><p><strong><em> [</em></strong><strong><em>2]</em></strong><em> Source: Annex D of the Updated Energy and Emissions Projections (EEP): 2014 (DECC). Based on all policies listed in EEP, including those introduced before as well as after the publication of the Low Carbon Transition Plan (LCTP) 2009</em></p><p> </p><p> </p><p> </p>
unstar this property answering member printed Lord Bourne of Aberystwyth more like this
star this property grouped question UIN HL991 more like this
star this property question first answered
less than 2015-07-07T16:31:57.56Zmore like thismore than 2015-07-07T16:31:57.56Z
star this property answering member
4282
star this property label Biography information for Lord Bourne of Aberystwyth more like this
star this property tabling member
1660
unstar this property label Biography information for Lord Judd more like this
386882
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department for Energy and Climate Change more like this
star this property answering dept id 63 more like this
star this property answering dept short name Energy and Climate Change more like this
star this property answering dept sort name Energy and Climate Change more like this
star this property hansard heading Carbon Emissions more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what proportion of their 2020 carbon emissions reduction target they intend to achieve through energy efficiency measures. more like this
star this property tabling member printed
Lord Judd more like this
star this property uin HL991 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-07more like thismore than 2015-07-07
star this property answer text <p>The Climate Change Act (2008) requires the Government to set legally binding ‘carbon budgets’ to meet the objective of reducing emissions by at least 80% in 2050 from 1990 levels. The Act requires that the UK’s emissions in the third carbon budget period, which covers 2020, are at least 34% below the 1990 baseline for emissions.</p><p>The Government has not set specific targets for how much of the emissions reductions required for each carbon budget should come from different emissions sources, for example heat, electricity or transport. This is to provide sufficient flexibility to ensure carbon savings are delivered across the economy in the most cost effective way.</p><p>However, DECC does produce projections of UK emissions that account for the impact of Government policies. The last projections published in September 2014 [1] showed that the UK was on track to meet the second (2013-17) and third (2018-22) budgets having already met the first carbon budget (2008-12).</p><p>In 2020, policies [2] which drive improvements in energy efficiency (across all sectors) are projected to contribute 61% of the total reduction in emissions and policies influencing the uptake of low-carbon heat technologies are projected to contribute 5%. Other policies such as Building Regulations also support the reduction of heat emissions from buildings for example through the requirement to install a condensing boiler in most cases when a boiler needs to be replaced.</p><p><em><strong>[1]</strong></em><em> Updated Energy and Emissions Projections: 2014 (DECC)</em></p><p><strong><em> [</em></strong><strong><em>2]</em></strong><em> Source: Annex D of the Updated Energy and Emissions Projections (EEP): 2014 (DECC). Based on all policies listed in EEP, including those introduced before as well as after the publication of the Low Carbon Transition Plan (LCTP) 2009</em></p><p> </p><p> </p><p> </p>
unstar this property answering member printed Lord Bourne of Aberystwyth more like this
star this property grouped question UIN HL992 more like this
star this property question first answered
less than 2015-07-07T16:31:57.44Zmore like thismore than 2015-07-07T16:31:57.44Z
star this property answering member
4282
star this property label Biography information for Lord Bourne of Aberystwyth more like this
star this property tabling member
1660
unstar this property label Biography information for Lord Judd more like this
386881
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Foreign and Commonwealth Office more like this
star this property answering dept id 16 more like this
star this property answering dept short name Foreign and Commonwealth Office more like this
star this property answering dept sort name Foreign and Commonwealth Office more like this
star this property hansard heading Crimes against Humanity more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty’s Government what action they have taken to review the readiness of the United Kingdom to respond to crimes of atrocity and developing threats of genocide and other crimes against humanity anywhere in the world. more like this
star this property tabling member printed
Lord Judd more like this
star this property uin HL990 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-13more like thismore than 2015-07-13
star this property answer text <p>The British Government’s global network of embassies, strong international partnerships, and early warning mechanisms give the UK significant insight into emerging threats. The UK remains committed to the Responsibility to Protect and seeks to respond to developing threats of atrocity crimes or genocide including through prevention projects, sanctions regimes or support for justice systems. Our seat on the UN Security Council also means we swiftly engage where a threat of such crimes emerges. Where prevention has failed, it is the international community's responsibility to take collective action, through diplomatic, humanitarian and other means. Where necessary, the UN Security Council should be ready to authorise coercive measures under Chapter VII of the UN Charter.</p> more like this
unstar this property answering member printed Baroness Anelay of St Johns more like this
star this property question first answered
less than 2015-07-13T13:24:48.577Zmore like thismore than 2015-07-13T13:24:48.577Z
star this property answering member
3474
star this property label Biography information for Baroness Anelay of St Johns more like this
star this property tabling member
1660
unstar this property label Biography information for Lord Judd more like this